CVS Could Decline Another 20% From Here

Expect further declines for the shares.

We're Changing Our DexCom Strategy as the Shares Move Higher

Here's what traders should do now.

Stay Alert as UnitedHealth Tests a Key Indicator

Previous tests were buying opportunities in October and May and June.

I'm Taking the Conservative Route With My Money

It's time to play defensive as nearly all the economic signs point to a slowing economy, which won't be good for stocks.

This Infection-Fighting Biotech Is Recovering Nicely

After a deal with GlaxoSmithKline, the small-cap antibiotic developer Spero Therapeutics should get a shot as an options play.

Centene's Charts Don't Feel Very Good

Here's what to avoid with this healthcare provider.

Novavax's Covid Vaccine May Pinch, But the Charts Really Hurt

Shares of Novavax are looking weak and in need of a booster, according to the technicals.

My Strategy to Buy Beam Therapeutics

Let's look at the charts and indicators.

Humana's Charts Look Healthy and Headed Higher

The technical setup of the healthcare provider's stock is bullish.

GoodRx Stock Looks Ready to Be Priced Like a Generic Drug

The charts don't look promising for GDRX.